Husam Y. Zaidan

Statistics

Publications

Citations

310

H-Index

Active since

2021

Affiliations

PDX Pharmaceuticals (United States)(Current)

Oregon Health & Science University

Husam Y. Zaidan is an author at PDX Pharmaceuticals (United States) specializing in drug delivery, cancer immunotherapy nanoparticles, and immunology.

Publications per year

2021–2022

Publications

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment

Moataz Reda, Worapol Ngamcherdtrakul, Molly A. Nelson et al. · Nature Communications · 2022 · 189 citations · Full text

Pharmacy, Immunology, Oncology +17

In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response

Worapol Ngamcherdtrakul, Moataz Reda, Molly A. Nelson et al. · Advanced Materials · 2021 · 73 citations · Full text

Medicine, Immunology, Oncology +17

Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2<b>+</b> Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis

Worapol Ngamcherdtrakul, Daniel S. Bejan, William Cruz‐Muñoz et al. · Small · 2022 · 48 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

1–3 of 3